Medpace Holdings, Inc. (MEDP)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

11 annual periodsNewest to oldest
20252024202320222021202020192018201720162015
Revenue$2.53B$2.11B$1.89B$1.46B$1.14B$925.9M$861.0M$704.6M$436.2M$421.6M$359.1M
Operating income$534.9M$446.9M$336.8M$278.7M$198.6M$167.0M$127.3M$101.0M$64.9M$52.5M$20.6M
EBITDAderived$563.1M$476.1M$363.2M$301.0M$219.7M$186.6M$150.5M$139.8M$111.3M$110.6M$90.1M
Net income$451.1M$404.4M$282.8M$245.4M$181.8M$145.4M$100.4M$73.2M$39.1M$13.4M−$8.7M
Basic EPSper diluted share$15.64$13.06$9.20$7.57$5.06$4.07$2.79$2.05$1.00$0.38-$0.28
Diluted EPSper diluted share$15.28$12.63$8.88$7.28$4.81$3.84$2.67$1.97$0.98$0.37-$0.28

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys1$652.22 disclosed value
Sells (SEC code S)41$338.30M disclosed value
42 recent transactions
TransactionInsiderTypeSharesPriceValueOwned after
May 28, 2026Form 4EWALD STEPHEN PGeneral Counsel & Corp. Secy.SellCommon Stock16.3K$450.00$7.36M20.3K
Mar 17, 2026Form 4GEIGER JESSE JPresidentSellCommon Stock31.7K$455.30$14.44M15.0K
Dec 3, 2025Form 4Troendle August J.CEOSellCommon Stock668$590.69$394.6K646.2K
Dec 2, 2025Form 4Troendle August J.CEOSellCommon Stock5.7K$590.47$3.36M646.9K
Dec 1, 2025Form 4Troendle August J.CEOSellCommon Stock23.2K$593.25$13.75M652.5K